Decreased insulin binding to lymphocytes from diabetic subjects.

UNLABELLED We have studied insulin binding to circulating lymphocytes isolated from 20 untreated adult, nonobese, nonketotic, diabetic subjects with fasting hyperglycemia, 20 normal subjects, and four patients with fasting hyperglycemia secondary to chronic pancreatitis. The results of these studies show that lymphocytes from diabetic patients have decreased ability to specificity bind insulin when compared to lymphocytes from normal subjects. For example, when lymphocytes from diabetic patients and a trace amount of [(125)I]insulin (3.3 x 10(-11) M) were incubated, binding was less than 50% of the value obtained with lymphocytes from normal subjects (2+/-0.2% vs. 4.2+/-0.4%). Furthermore, the data show that lymphocytes from diabetic patients have only 1,200 insulin receptor sites per cell compared to 2,200 sites per cell for lymphocytes from normal subjects. Competitive inhibition studies using unlabeled insulin indicate that the affinity for insulin of lymphocytes from both groups is comparable. Consequently the decreased insulin binding of diabetics' lymphocytes is primarily due to a decreased number of available receptors rather than decreased binding affinity. This decreased insulin binding is not due to chronic hyperglycemia since insulin binding to lymphocytes, obtained from four patients with fasting hyperglycemia secondary to chronic pancreatitis, was completely normal. The possibility that some factor present in the plasma of diabetic patients could cause decreased insulin binding also seems unlikely since we could demonstrate no in vitro effects of diabetics' plasma on insulin binding. Lastly, the proportion of lymphocytes which were thymus derived and bone marrow derived were the same in each of the study groups indicating that differences in lymphocyte subpopulations do not account for our results. IN CONCLUSION (a) lymphocytes from nonobese, untreated, adult diabetic patients with fasting hyperglycemia demonstrate a decreased ability to bind insulin; (b) this decreased insulin binding to lymphocytes obtained from diabetic patients can be accounted for primarily by an absolute decrease in the number of available receptor sites per cell; and (c) these data suggest that this defect in insulin binding is a primary phenomenon.

[1]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[2]  S A BERSON,et al.  Quantitative aspects of the reaction between insulin and insulin-binding antibody. , 1959, The Journal of clinical investigation.

[3]  J Roth,et al.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance. , 1973, The Journal of biological chemistry.

[4]  L. Herzenberg,et al.  Identification and quantitation of thymus-derived lymphocytes in human peripheral blood. , 1974, Journal of immunology.

[5]  D. Neville,et al.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Neville,et al.  Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. , 1971, Biochemical and biophysical research communications.

[7]  D. Porte,et al.  The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. , 1973, The Journal of clinical investigation.

[8]  J. Roth,et al.  Insulin receptors in human circulating lymphocytes: application to the study of insulin resistance in man. , 1973, The Journal of clinical endocrinology and metabolism.

[9]  A. Böyum.  A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[10]  J. Roth.  Peptide hormone binding to receptors: a review of direct studies in vitro. , 1973, Metabolism: clinical and experimental.

[11]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[12]  M. Rodbell.  METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. , 1964, The Journal of biological chemistry.

[13]  C. Kahn,et al.  Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse , 1972, FEBS letters.

[14]  J. Roth,et al.  Characteristics of the human lymphocyte insulin receptor. , 1973, The Journal of biological chemistry.

[15]  G. Reaven,et al.  Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. , 1974, The Journal of clinical investigation.

[16]  G. Reaven,et al.  The human lymphocyte: a model for the study of insulin-receptor interaction. , 1974, The Journal of clinical endocrinology and metabolism.

[17]  G. Reaven,et al.  Study of the Relationship Between Glucose and Insulin Responses to an Oral Glucose Load in Man , 1968, Diabetes.

[18]  K. Zierler,et al.  Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. , 1962, The Journal of clinical investigation.

[19]  C. F. Gastineau,et al.  Standardization of the oral glucose-tolerance test. , 1969, Annals of internal medicine.